Recruiting

HYDEMRandomized Controlled Study Evaluating the Efficacy of Hypnosis by Deportee Method Adapted to Nuclear Medicine

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Ericksonian Hypnosis

+ Hypnosis

Other
Who is being recruted

Alzheimer Disease+11

+ Mental Disorders

+ Brain Diseases

From 18 to 80 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: May 2023
See protocol details

Summary

Principal SponsorCentral Hospital, Nancy, France
Study ContactAnne-Sophie HueMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 26, 2023

Actual date on which the first participant was enrolled.

This study is exploring a new way to help patients feel less anxious during nuclear medicine scans, which can be long and require them to stay still. These exams often make patients nervous, which can affect the quality of the results. Traditionally, a type of therapy called Ericksonian hypnosis is used to help patients stay calm, but it requires the therapist to be close to the patient, which can expose them to radiation. This study tests if hypnosis can be just as effective when delivered remotely using a headset and microphone, reducing radiation exposure for the therapist and potentially improving the patient experience. Participants in the study will receive hypnosis sessions either through conventional means, with the therapist nearby, or remotely, using technology. The study observes if the remote method can calm patients just as well as the traditional approach. By measuring anxiety levels before and after the hypnosis sessions using a simple scale, the research aims to determine if the remote method is equally effective. This pilot study will help in planning larger studies and ensure that remote hypnosis can be a safe and effective option in the future for both patients and therapists.

Official TitleRandomized Controlled Study Evaluating the Efficacy of Hypnosis by Deportee Method Adapted to Nuclear Medicine
NCT06116084
Principal SponsorCentral Hospital, Nancy, France
Study ContactAnne-Sophie HueMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

100 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Alzheimer DiseaseMental DisordersBrain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesDementiaHeart DiseasesCardiomyopathiesMyocarditisNeoplasmsNervous System DiseasesNeurodegenerative DiseasesNeurocognitive DisordersTauopathies

Criteria

6 inclusion criteria required to participate
Patient referred for a scan or PET scan

Patient with a score > 11 on the STAI-6 scale.

Person, speaking and understanding French

Having received complete information on the organization of the research and having signed the informed consent

Show More Criteria

8 exclusion criteria prevent from participating
People who have taken an anxiolytic treatment before going to nuclear medicine.

Persons referred for a neurological examination.

People with cognitive or auditory problems, or with a major depressive episode.

Persons with cardiac rhythm disorders (cardiac arrhythmias)

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
An Ericksonian hypnosis session given to patients during a scintigraphic or PET examination, in a conventional manner, i.e. the hypnotherapist (MERM) is close to the patient in the examination room at the time of the session and communicates with him/her without any special device dedicated to this purpose.

Group II

Experimental
Hypnosis session with headphones and microphones

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Nancy Hospital

Vandœuvre-lès-Nancy, FranceOpen Nancy Hospital in Google Maps
Recruiting
One Study Center